Literature DB >> 24194405

Release of prostaglandins from human polymorphonuclear leukocytes.

R B Zurier1, D M Sayadoff.   

Abstract

Human PMNs release prostaglandins E and F to the surrounding medium when these cells are exposed to zymosan. PGE1 is the prostaglandin compound found in highest concentration in the medium, and the PGE/PGF balance is approximately 3∶1. Release of prostaglandins is not due to platelet contamination. Agents which inhibit prostaglandin synthesis (indomethacin, aspirin) prevent release of prostaglandins from phagocytic cells. Addition to cells of dibutyryl cyclic 3',5'-adenosine monophosphate produces striking increases in concentrations of prostaglandins released during ingestion of zymosan. Prostaglandins appear to be synthesized by human PMN during phagocytosis, and their release from cells may help regulate the inflammatory response.

Entities:  

Year:  1975        PMID: 24194405     DOI: 10.1007/BF00918062

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  28 in total

1.  Metalloenzymes and myocardial infarction. II. Malic and lactic dehydrogenase activities and zinc concentrations in serum.

Authors:  D D ULMER; B L VALLEE; W E WACKER
Journal:  N Engl J Med       Date:  1956-09-06       Impact factor: 91.245

2.  The role of cyclic 3',5' adenosine monophosphate in the specific cytolytic activity of lymphocytes.

Authors:  C S Henney; H R Bourne; L M Lichtenstein
Journal:  J Immunol       Date:  1972-06       Impact factor: 5.422

Review 3.  Biological significance of the prostaglandins.

Authors:  P W Ramwell; J E Shaw
Journal:  Recent Prog Horm Res       Date:  1970

4.  Immunological release of histamine and slow-reacting substance of anaphylaxis from human lung. I. Modulation by agents influencing cellular levels of cyclic 3',5'-adenosine monophosphate.

Authors:  R P Orange; W G Austen; K F Austen
Journal:  J Exp Med       Date:  1971-09-01       Impact factor: 14.307

5.  Lysosomal enzyme release from human leukocytes: mediation by the alternate pathway of complement activation.

Authors:  I M Goldstein; M Brai; A G Osler; G Weissmann
Journal:  J Immunol       Date:  1973-07       Impact factor: 5.422

6.  The distribution of prostaglandins in inflammatory exudates.

Authors:  J P Giroud; J P Velo; J Timsit; D A Willoughby
Journal:  Pol J Pharmacol Pharm       Date:  1974 Jan-Apr

7.  Formation and release of prostaglandins by platelets in response to thrombin.

Authors:  J B Smith; A L Willis
Journal:  Br J Pharmacol       Date:  1970-11       Impact factor: 8.739

8.  Drugs which inhibit prostaglandin biosynthesis.

Authors:  R J Flower
Journal:  Pharmacol Rev       Date:  1974-03       Impact factor: 25.468

9.  Suppression of acute and chronic inflammation in adrenalectomized rats by pharmacologic amounts of prostaglandins.

Authors:  R B Zurier; S Hoffstein; G Weissmann
Journal:  Arthritis Rheum       Date:  1973 Sep-Oct

10.  Effect of prostaglandin E 1 on adjuvant arthritis.

Authors:  R B Zurier; F Quagliata
Journal:  Nature       Date:  1971-12-03       Impact factor: 49.962

View more
  14 in total

1.  A cat model for the evaluation of mechanisms of bone resorption: induction of bone loss by simulated immune complexes and inhibition by indomethacin.

Authors:  M Torbinejad; J Clagett; D Engel
Journal:  Calcif Tissue Int       Date:  1979       Impact factor: 4.333

Review 2.  Modulation of phagocytic cell function.

Authors:  P A Henricks; J Verhoef; F P Nijkamp
Journal:  Vet Res Commun       Date:  1986-05       Impact factor: 2.459

3.  The reactivity of neutrophils at the site of an acute inflammatory reaction as measured by chemiluminescence.

Authors:  J Bird; J P Giroud
Journal:  Agents Actions       Date:  1984-10

4.  Neutrophil aggregation during migration in vivo.

Authors:  G Egger; S Porta; D Gollmann
Journal:  Inflammation       Date:  1982-06       Impact factor: 4.092

5.  Effect of calcium, magnesium, and cytochalasin B on arachidonic acid-induced neutrophil aggregation.

Authors:  J T O'Flaherty
Journal:  Inflammation       Date:  1980-03       Impact factor: 4.092

Review 6.  Prostaglandins, thromboxanes, and polymorphonuclear leukocytes: mediation and modulation of inflammation.

Authors:  I M Goldstein; C L Malmsten; B Samuelsson; G Weissmann
Journal:  Inflammation       Date:  1977-12       Impact factor: 4.092

7.  Antioxidation theory of non-steroidal anti-inflammatory drugs based upon the inhibition of luminol-enhanced chemiluminescence from the myeloperoxidase reaction.

Authors:  G Pekoe; K Van Dyke; D Peden; H Mengoli; D English
Journal:  Agents Actions       Date:  1982-07

8.  Generation of a chemotactic lipid from a arachidonic acid by exposure to a superoxide-generating system.

Authors:  H D Perez; B B Weksler; I M Goldstein
Journal:  Inflammation       Date:  1980-09       Impact factor: 4.092

9.  Comparison of the effects of antioxidant non-steroidal anti-inflammatory drugs against myeloperoxidase and hypochlorous acid luminol-enhanced chemiluminescence.

Authors:  G Pekoe; K Van Dyke; H Mengoli; D Peden; D English
Journal:  Agents Actions       Date:  1982-04

10.  Antrafenine: anti-inflammatory activity with respect to oedema and leucocyte infiltration in the rat.

Authors:  C J Dunn; M Prouteau; M Delahaye; T Purcell; D Branceni
Journal:  Agents Actions       Date:  1984-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.